STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea
- Conditions
- NeoplasmsDiarrhea
- Registration Number
- NCT00050635
- Lead Sponsor
- Novartis Pharmaceuticals
- Brief Summary
Currently there is an ongoing clinical trial for patients with chemotherapy induced diarrhea. This trial is being conducted to evaluate the efficacy of two dose levels (30 mg and 40 mg) of an investigational drug in reducing the occurrence of severe (Grade 3 or 4) diarrhea during chemotherapy. Eligible patients must either have experienced NCI Common Toxicity Grade 1 - 4 chemotherapy-induced diarrhea during previous chemotherapy treatment or be experiencing Grade 1-4 chemotherapy-induced diarrhea currently.
In order to participate in this clinical trial, patients must be male or female 18 years of age or older. Inclusion into this investigational drug trial is based on the protocol entry criteria and a detailed evaluation from a participating trial investigator
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from baseline and at 6 months in the proportion of patients with NCI Grades 3 and/or 4 diarrhea during chemotherapy
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (33)
Kenmar Research Institute
πΊπΈLos Angeles, California, United States
Bay Area Cancer Research Group
πΊπΈConcord, California, United States
Compassionate Cancer Care medical Group, Inc.
πΊπΈFountain Valley, California, United States
California Cancer Care, Inc.
πΊπΈGreenbrae, California, United States
Pacific Shores Medical Center
πΊπΈLong Beach, California, United States
Oncology Hematology Group of South Florida
πΊπΈMiami, Florida, United States
Pasco Hernando Oncology Associates
πΊπΈNew Port Richey, Florida, United States
Mid-Florida Hematology & Oncology Centers, PA
πΊπΈOrange City, Florida, United States
Oncology & Hematology Associates of West Broward
πΊπΈTamarac, Florida, United States
Creticos Cancer Center
πΊπΈChicago, Illinois, United States
Scroll for more (23 remaining)Kenmar Research InstituteπΊπΈLos Angeles, California, United States